Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Paris  >  Innate Pharma    IPH   FR0010331421

INNATE PHARMA

(IPH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations
Official Publications
01/11/21Corporate Officers and Executives' transactions in the company's securities - Sale 
01/07/21Corporate Officers and Executives' transactions in the company's securities - Sale 
01/07/21Corporate Officers and Executives' transactions in the company's securities - Sale 
01/07/21Corporate Officers and Executives' transactions in the company's securities - Sale 
01/01/21Corporate Officers and Executives' transactions in the company's securities - Sale 
01/01/21Corporate Officers and Executives' transactions in the company's securities - Sale 
12/21/20Corporate Officers and Executives' transactions in the company's securities - Sale 
12/21/20Corporate Officers and Executives' transactions in the company's securities - Sale 
12/21/20Corporate Officers and Executives' transactions in the company's securities - Sale 
12/17/20Corporate Officers and Executives' transactions in the company's securities - Sale 
12/17/20Corporate Officers and Executives' transactions in the company's securities - Sale 
12/14/20Corporate Officers and Executives' transactions in the company's securities - Sale 
12/14/20Corporate Officers and Executives' transactions in the company's securities - Sale 
12/14/20Corporate Officers and Executives' transactions in the company's securities - Sale 
12/09/20Corporate Officers and Executives' transactions in the company's securities - Sale 
12/09/20Corporate Officers and Executives' transactions in the company's securities - Sale 
12/09/20Corporate Officers and Executives' transactions in the company's securities - Sale 
12/04/20Corporate Officers and Executives' transactions in the company's securities - Sale 
12/04/20Corporate Officers and Executives' transactions in the company's securities - Sale 
12/04/20Corporate Officers and Executives' transactions in the company's securities - Sale 
12/01/20Corporate Officers and Executives' transactions in the company's securities - Sale 
11/30/20Corporate Officers and Executives' transactions in the company's securities - Sale 
11/26/20Press Release 
11/17/203rd quarter results 
11/17/203rd quarter results 
11/03/20Corporate Officers and Executives' transactions in the company's securities - Sale 
11/03/20Corporate Officers and Executives' transactions in the company's securities - Sale 
10/23/20Crossing thresholds 
10/13/20Monthly statement on outstanding equity shares and voting rights 
10/13/20Monthly statement on outstanding equity shares and voting rights 
09/30/203rd quarter report 
09/30/20Monthly statement on outstanding equity shares and voting rights 
09/30/20Monthly statement on outstanding equity shares and voting rights 
09/16/20Corporate Officers and Executives' transactions in the company's securities - Purchase 
09/08/20Half-year results 
08/12/20Monthly statement on outstanding equity shares and voting rights 
08/12/20Monthly statement on outstanding equity shares and voting rights 
08/09/20Half-year results 
07/31/20Monthly statement on outstanding equity shares and voting rights 
07/27/20Corporate Officers and Executives' transactions in the company's securities - Purchase 
07/27/20Corporate Officers and Executives' transactions in the company's securities - Purchase 
07/27/20Corporate Officers and Executives' transactions in the company's securities - Purchase 
06/30/20Half-year report 
06/30/20Half-year report 
05/19/20Proxy Statments 
05/12/201st quarter earnings 
05/12/201st quarter earnings 
04/30/20Monthly statement on outstanding equity shares and voting rights 
04/30/20Monthly statement on outstanding equity shares and voting rights 
04/17/20Amendment 
04/14/20Mixed general shareholder meeting 
04/14/20Mixed general shareholder meeting 
04/10/20Mixed general Shareholders meeting 
03/10/20Press Release 
03/10/20Annual results 
03/10/20Annual results 
02/18/20Corporate Officers and Executives' transactions in the company's securities - Purchase 
01/27/20Corporate Officers and Executives' transactions in the company's securities - 
12/31/19SEC Filing 20 F 
12/31/19Report 
12/04/19Provisional calendar 
11/13/193rd quarter earnings 
11/13/193rd quarter earnings 
11/12/19Corporate Officers and Executives' transactions in the company's securities - Purchase 
11/06/19Monthly statement on outstanding equity shares and voting rights 
11/06/19Monthly statement on outstanding equity shares and voting rights 
11/05/19Corporate Officers and Executives' transactions in the company's securities - Purchase 
10/28/19Crossing thresholds 
10/18/19Corporate Officers and Executives' transactions in the company's securities - 
10/17/19Public takeover bid 
09/13/19Half-year results 
09/13/19Half-year results 
07/17/19Monthly statement on outstanding equity shares and voting rights 
07/17/19Monthly statement on outstanding equity shares and voting rights 
07/16/19Corporate Officers and Executives' transactions in the company's securities - Sale 
1  2Next
Upcoming event on INNATE PHARMA